Taxonomy

CMTA Appoints Science and Technology Veteran, Patricia Verduin, PhD, to the Board of Directors

The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth

Read More

TAKE ACTION! Sign the Petition to Accelerate CMT-SORD

What is CMT-SORD? In 2019, with Charcot-Marie-Tooth Association (CMTA) funding,

Read More

Leading the Way: The CMTA Invests More Than $200K in Cutting-Edge CMT1A Organoid Research

The CMTA’s new $200K+ investment accelerates CMT1A organoid research, revolutionizing

Read More

The CMTA Mourns the Loss of Scientific Advisory Board Member and Esteemed CMT Clinical Researcher

It is with the heaviest of hearts that the Charcot-Marie-Tooth

Read More

CMT2S Breakthrough

In a recent announcement, Vanda Pharmaceuticals Inc. shared that the

Read More

CMTA Alliance Partner, Applied Therapeutics, Announces Positive 12-Month Results in its Ongoing INSPIRE Phase III Trial for CMT-SORD

In a statement released on February 15, 2024, by Charcot-Marie-Tooth

Read More

The CMTA Appoints Professor Charlotte Sumner, M.D., to its Scientific Advisory Board

The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth

Read More

CMTA Appoints Biotech Industry Veteran Suzanne Bruhn, PhD as New CEO

GLENOLDEN, Pa., November 6, 2023 – The Charcot-Marie-Tooth Association announced

Read More

CMTA Funds Preclinical Work on Modulating Unfolded Protein Response in CMT1B Mice

The Charcot-Marie-Tooth (CMT) Association announced a $33,000 grant on April

Read More

Vera Fridman, MD joins the CMTA STAR Advisory Board

In a suite of exciting appointments, the Charcot-Marie-Tooth Association (CMTA)

Read More